realestate

Boston Life Sciences Conference 2025: Convergence of Biotech and Health Innovations

Boston Life Sciences, Biotech, and Health Facilities Conference Set for Highly Anticipated Industry Event.

T
he Boston Life Sciences, Biotech, and Health Facilities Conference is set to take place at the Burlington Marriott Hotel in Massachusetts. This influential gathering brings together industry leaders from biotech, healthcare development, and life sciences facility design for a day of insights, trends, and transformative ideas.

    Registration and networking begin at 7:00 AM, followed by an opening address that sets the tone for the morning's discussions. The conference is curated by Boston Real Estate Times and Life Sciences Times, with Upendra Mishra moderating a panel featuring leading voices in the life sciences ecosystem.

    The expert speaker lineup includes:

    Ben Bradford, VP of Economic Development and Workforce at Mass Biotech Council

    Jonathan Cocker, Principal at Maugel DeStefano Architects

    Samuel Crossan, Managing Director at JLL

    Bob Doherty, VP of Development at Boston Development Group

    Gary Kaufman, COO at ABI-LAB

    Dr. Purnanand Sarma, CEO at Aro Biotherapeutics

    Each speaker will deliver a dynamic 5-6 minute presentation offering unique insights into their specialty. Topics include healthcare facility design, real-world case studies, market trends, biotech incubation, policy and venture capital climate, and global biotech innovation.

    Following the presentations, the program transitions into a lively panel discussion where attendees can engage directly with industry titans shaping the future of healthcare and biotech. This conference is a must-attend for anyone involved in real estate development, architecture, biotech investment, policy leadership, or scientific research.

    Join us as Boston continues to lead the charge in redefining what's possible in life sciences and healthcare innovation. Click here to register today!

Scientists and entrepreneurs gather at Boston conference for biotech and health innovation discussions.